The COVID Clots: A Full Measure Town Hall

Full Measure with Sharyl Attkisson2 minutes read

Dr. Vaughn treated patients with post-COVID complications through triple anticoagulant therapy, showing significant improvement. Various individuals experienced debilitating effects post-COVID or vaccination, with treatments focusing on addressing vascular issues and clotting problems.

Insights

  • Dr. Jordan Vaughn treated a wide range of patients with post-COVID complications, showcasing the diverse impact of these conditions on individuals across different age groups and lifestyles.
  • Spike protein exposure from COVID infections and vaccinations can lead to amyloid fibrin formation, causing clotting issues that obstruct small vessels and impede oxygen delivery, highlighting a crucial factor contributing to post-COVID complications.

Get key ideas from YouTube videos. It’s free

Recent questions

  • What are some common post-COVID complications?

    Post-COVID complications include blood clots, vision issues, brain fog, and heart problems.

  • How can post-COVID complications be treated?

    Post-COVID complications can be treated with triple anticoagulant therapy.

  • What is the Microvascular Research Foundation?

    The Microvascular Research Foundation was founded by Dr. Jordan Vaughn to address post-COVID complications.

  • What is the role of spike proteins in COVID infections?

    Spike proteins in COVID infections can lead to vascular issues and clotting problems.

  • How effective is Ivermectin in treating post-COVID complications?

    Ivermectin is a highly effective drug, showing positive responses in about 70% of patients with varying degrees of effectiveness.

Related videos

Summary

00:00

Post-COVID Complications: Treatment and Recovery Success

  • Patient experienced sudden physical distress during a workout, leading to dizziness, lethargy, and inability to feel legs.
  • Doctor prescribed triple anticoagulant therapy, resulting in significant improvement within two weeks.
  • Full Measure Town Hall with Cheryl Atkinson discusses post-COVID complications, including blood clots, vision issues, brain fog, and heart problems.
  • Dr. Jordan Vaughn treated over 1100 patients with post-COVID complications, ranging from athletes to elderly individuals.
  • Patients like Andy, Phil, and Hannah experienced various debilitating effects post-COVID or vaccination.
  • Dr. Vaughn diagnosed microclots throughout the body causing oxygen circulation issues in patients.
  • Treatment with triple anticoagulant therapy led to dramatic improvements in patients' symptoms.
  • 88-year-old Donald Carmichael and young athletes like Braden and Ellen experienced significant recovery under Dr. Vaughn's care.
  • Dr. Vaughn, an internal medicine specialist, founded the Microvascular Research Foundation to address post-COVID complications.
  • Dr. Vaughn explains the impact of the spike protein in COVID infections and vaccinations, leading to vascular issues and clotting problems.

14:57

"Health Issues Overlooked, Treatments Hindered by Pharma"

  • Many individuals realize something is wrong after experiencing coveting and failing to improve, getting sicker, or post-vaccination.
  • People may overlook treatable health issues due to aging or pre-existing conditions, assuming symptoms are normal.
  • Success stories include elderly individuals regaining health, avoiding assisted living or nursing homes.
  • Young athletes are often more aware of their bodies and health issues, even when scans show nothing.
  • Medical diagnostics often rely on yes or no diagnoses, lacking the ability to detect issues at the tissue level.
  • Medicine faces challenges in identifying issues at the small vessel level, hindering accurate diagnoses.
  • Fibrin, a response to infection, forms clots but differs in response to the spike protein from COVID and vaccines.
  • Spike protein exposure leads to amyloid fibrin formation, obstructing small vessels and impeding oxygen delivery.
  • Yale research links persistent symptoms post-vaccination to long COVID-like effects, possibly due to spike proteins.
  • Ivermectin and other treatments were hindered by pharmaceutical interests, threatening profits and vaccination campaigns.

28:38

Treatment options for Mast Cell Activation Syndrome

  • Immune cells like macrophages and mast cells can become hyperactive, leading to Mast Cell Activation Syndrome triggered by clotting.
  • Mitochondrial problems affect energy production in cells, impacting their functionality.
  • Ivermectin is a highly effective drug, showing positive responses in about 70% of patients, with varying degrees of effectiveness.
  • Low-dose Naltrexone offers immunomodulatory benefits, alleviating nerve pains, fatigue, and brain fog.
  • Medications like antihistamines (Claritin, Zyrtec) and Pepcid suppress mast cell activity, while ketotaphin stabilizes mast cells.
  • Sequential therapeutic trials are often necessary, with medication lists growing as treatment progresses.
  • Mast Cell Activation Syndrome shares similarities with myelogic Encephalitis or chronic fatigue syndrome, with treatments showing varying success rates.
  • Safe medicines with proven safety profiles are used in trials, with adjustments made based on patient responses.
  • Dr. Whelan's prescient warnings about potential vascular issues with COVID vaccines were not heeded by the FDA.
  • Patients like Hannah Bourgeois have seen remarkable recoveries under Dr. Vaughn's treatment, with improvements in symptoms like fatigue, headaches, and hair loss.

45:06

"Vaccine benefits and risks for vulnerable populations"

  • Some individuals experienced an improvement in their health after receiving the vaccine, although there were concerns about potential nerve damage and balance issues post-vaccination.
  • Nerve damage, particularly small fiber neuropathy, could be linked to oxygen deprivation in tissues rather than solely to the vaccine's spike protein. Lower extremity problems may also be related to poor venous return affecting cardiac input.
  • Certain subpopulations, such as obese and immune deficient children, are more vulnerable to the virus, prompting caution with new vaccines that lack extensive human studies. Vaccination may benefit specific groups, but further research is needed on the new vaccine array's efficacy.
  • Resources for seeking information and assistance include websites like flccc.net for mechanistic-based therapies and guidance on navigating vaccination decisions, emphasizing the importance of finding a caring physician and taking an active role in healthcare decisions.
Channel avatarChannel avatarChannel avatarChannel avatarChannel avatar

Try it yourself — It’s free.